RELATED SOCIETY LINKS

Message sent on behalf of theImmunOptimize Network

Dear Colleagues,

We are conducting a research study to better understand healthcare provider attitudes, experiences, and institutional practices related to the use of monoclonal antibody (mAb) therapies for prevention or treatment of infections in immunocompromised patients. 

We invite healthcare providers involved in the care of immunocompromised populations to participate in a brief anonymous online survey.

The survey takes approximately 10 minutes to complete. At the end of the survey, participants may optionally indicate their willingness to participate in a paid follow-up interview.

To participate, please complete the survey at: https://redcap.link/ION_mAb_Survey 

Thank you for your participation.

Josh Hill, MD, FIDSA on behalf of the ImmunOptimize Network
Fred Hutch Cancer Center and University of Washington